Geographic Tongue Market Research Report, Diagnosis (Biopsy, Tests), Treatment (Topical Corticosteroids, Zinc Supplements, Topical Anaesthetic), End User (Hospitals & Clinics, Research Organization, Diagnostic Labs) - Global Forecast Till 2027
ID: MRFR/Pharma/3792-HCR | | Region: Global | 110 pages
Geographic Tongue Market Scenario
Geographic tongue or migratory glossitis is a benign condition which is characterized by the inflammation of the tongue. Under normal conditions the tongue is covered by a layer of small bumps-papillae, which tend to be missing in this medical condition. The symptoms for geographic tongue are inclusive of general discomfort of the tongue or mouth and soreness or a burning sensation of the tongue, which is often worsened by spicy or acidic foods. The susceptibility of geographic tongue is high in patients with psoriasis. Moreover, it is estimated that the geriatric population is more frequently diagnosed for the same condition. Thus, the increasing prevalence of the psoriasis along with the growing geriatric population are the major drivers for the market growth. According to the International Federation of Psoriasis in 2016, approximately 3% of the world’s population suffer from psoriasis accounting to more than 125 million people across the globe. According to the World Health Organization the global geriatric population is growing and is estimated to reach a 1.5 billion by 2050 from 524 million in 2010. Additionally, growing oral healthcare expenditures are estimated to fuel the market growth during the forecast period. However, lack of awareness along with the limited availability of the treatment procedures and low per capita healthcare expenditure in the middle and low income countries are estimated to restrain the market growth during the forecast period.
The Geographic Tongue Market is estimated to grow at an Approximate CAGR of 10.6% from 2017 to 2023.
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Research and development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Figure 1:- Geographic Tongue Market share, by Region
Sources: WHO, annual reports, press release, white paper, and company presentation
Key players for geographic tongue market
Quest Diagnostics (U.S.), Sonic Healthcare (Australia), Merck KGaA (Germany), Jost Chemical Co. (U.S.), Pfizer Inc. (U.S.), AstraZeneca (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Danaher (U.S.) and others are some of the key players in the geographic tongue market.
Segmentation
The Geographic Tongue Market is segmented on the basis of diagnosis, treatment, and end user.
On the basis of the diagnosis, the market is segmented into physical examinations, biopsy, tests, and others. The tests segment is sub-segmented into vitamin B testing, HLA B antigen testing, and others.
On the basis of the treatment, the market is segmented into topical corticosteroids, zinc supplements, topical anaesthetic, and others.
On the basis of the end user, the market is segmented into hospitals & clinics, research organization, diagnostic labs, and others.
Research Methodology 
Sources: WHO, annual reports, press release, white paper, and company presentation
Regional Analysis
America dominates the geographic tongue market owing to the presence of the developed healthcare sector and rising patient population for diseases like psoriasis. Moreover, increasing per capita healthcare expenditure followed by the presence of the developed economies like U.S. and Canada within the region boosts the market growth during the forecast period.
Europe stands second in the geographic tongue market. Rising research and development in healthcare sector, increasing government funding and presence of huge patient population are the major drivers for the market growth within the region. According to a study published in the Archives of Dermatological Research in 2016, the prevalence of the psoriasis in Germany was about 2.5% affecting 2.0 million people within the region.
Asia Pacific region holds the fastest growing market. The region is marked with increasing healthcare expenditures and developing pharmaceutical & biotechnological sector and growing geriatric population. This, along with the presence of the developing economies like India and China provide huge opportunities for the Geographic Tongue Market growth.
The Middle East & Africa hold the least share in the geographic tongue market, which is attributed due the absence of developed healthcare services, especially in the African Region. A majority of the market share within this region is held by the Middle East. This can be attributed due to the huge healthcare expenditures by the developed economies like Kuwait, Qatar, Dubai and others within the region.
Frequently Asked Questions (FAQ) :
Geographic tongue market is projected to grow at a 10.6% CAGR between 2017-2023.
The Americas is expected to dominate the geographic tongue market.
Growing oral healthcare expenditure and rising prevalence of psoriasis are the key factors driving the geographic tongue market growth.
Limited accessibility of treatment and lack of awareness may limit the geographic tongue market growth.
Notable players profiled in the geographic tongue market include Danaher (US), Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), AstraZeneca (US), Pfizer Inc. (US), Jost Chemical Co. (US), Merck KGaA (Germany), Sonic Healthcare (Australia), and Quest Diagnostics (US).
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Geographic Tongue Market, by Diagnosis
6.1 Introduction
6.2 Physical Examinations
Market Estimates & Forecast, 2020 – 2027
6.3 Biopsy
Market Estimates & Forecast, 2020 – 2027
6.4 Tests
Market Estimates & Forecast, 2020 – 2027
6.4.1 Vitamin B Testing
6.4.2 HLA B Antigen Testing
6.4.3 Others
6.5 Others
Chapter 7. Global Geographic Tongue Market, by Treatment
7.1 Introduction
7.2 Topical Corticosteroids
Market Estimates & Forecast, 2020 – 2027
7.3 Zinc Supplements
Market Estimates & Forecast, 2020 – 2027
7.4 Topical Anesthetic
Market Estimates & Forecast, 2020 – 2027
7.5 Others
Chapter 8. Global Geographic Tongue Market, by End User
8.1 Introduction
8.2 Hospitals & Clinics
Market Estimates & Forecast, 2020 – 2027
8.3 Research Organization
Market Estimates & Forecast, 2020 – 2027
8.4 Diagnostic Labs
Market Estimates & Forecast, 2020 – 2027
8.5 Others
Chapter 9. Global Geographic Tongue Market, by Region
9.1 Introduction
9.2 The Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Quest Diagnostics
11.1.1 Company Overview
11.1.2 Treatment Overview
11.1.3 Financials
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Sonic Healthcare
11.2.1 Company Overview
11.2.2 Treatment Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Merck KGaA
11.3.1 Company Overview
11.3.2 Treatment Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Jost Chemical Co.
11.4.1 Company Overview
11.4.2 Treatment/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Pfizer Inc.
11.5.1 Company Overview
11.5.2 Treatment Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 AstraZeneca
11.6.1 Company Overview
11.6.2 Treatment Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 F. Hoffmann-La Roche Ltd
11.7.1 Overview
11.7.2 Treatment Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Abbott
11.8.1 Overview
11.8.2 Treatment Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Danaher
11.9.1 Overview
11.9.2 Treatment Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Geographic Tongue Industry
Chapter13 Appendix
LIST OF TABLES
Table 1 Global Geographic Tongue Industry Synopsis, 2020 – 2027
Table 2 Global Geographic Tongue Market Estimates and Forecast, 2020 – 2027, (USD Million)
Table 3 Global Geographic Tongue Market by Region, 2020 – 2027, (USD Million)
Table 4 Global Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 5 Global Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 6 Global Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 7 North America Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 8 North America Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 9 North America Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 10 U.S. Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 11 U.S. Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 12 U.S. Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 13 Canada Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 14 Canada Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 15 Canada Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 16 South America Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 17 South America Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 18 South America Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 19 Europe Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 20 Europe Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 21 Europe Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 22 Western Europe Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 23 Western Europe Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 24 Western Europe Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 25 Eastern Europe Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 26 Eastern Europe Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 27 Eastern Europe Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 28 Asia Pacific Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 29 Asia Pacific Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 30 Asia Pacific Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
Table 31 Middle East & Africa Geographic Tongue Market by Diagnosis, 2020 – 2027, (USD Million)
Table 32 Middle East & Africa Geographic Tongue Market by Treatment, 2020 – 2027, (USD Million)
Table 33 Middle East & Africa Geographic Tongue Market by End Users, 2020 – 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Geographic Tongue Market
Figure 3 Segmentation Market Dynamics for Global Geographic Tongue Market
Figure 4 Global Geographic Tongue Market Share, by Diagnosis 2020
Figure 5 Global Geographic Tongue Market Share, by Treatment, 2020
Figure 6 Global Geographic Tongue Market Share, by End Users, 2020
Figure 7 Global Geographic Tongue Market Share, by Region, 2020
Figure 8 The Americas Geographic Tongue Market Share, by Country, 2020
Figure 9 Europe Geographic Tongue Market Share, by Country, 2020
Figure 10 Asia Pacific Geographic Tongue Market Share, by Country, 2020
Figure 11 Middle East & Africa Geographic Tongue Market Share, by Country, 2020
Figure 12 Global Geographic Tongue Market: Company Share Analysis, 2020 (%)
Figure 13 Quest Diagnostics: Key Financials
Figure 14 Quest Diagnostics: Segmental Revenue
Figure 15 Quest Diagnostics: Geographical Revenue
Figure 16 Sonic Healthcare: Key Financials
Figure 17 Sonic Healthcare: Segmental Revenue
Figure 18 Sonic Healthcare: Geographical Revenue
Figure 19 Merck KGaA: Key Financials
Figure 20 Merck KGaA: Segmental Revenue
Figure 21 Merck KGaA: Geographical Revenue
Figure 22 Jost Chemical Co.: Key Financials
Figure 23 Jost Chemical Co.: Segmental Revenue
Figure 24 Jost Chemical Co.: Geographical Revenue
Figure 25 Pfizer Inc.: Key Financials
Figure 26 Pfizer Inc.: Segmental Revenue
Figure 27 Pfizer Inc.: Geographical Revenue
Figure 28 AstraZeneca: Key Financials
Figure 29 AstraZeneca: Segmental Revenue
Figure 30 AstraZeneca: Geographical Revenue
Figure 31 F. Hoffmann-La Roche Ltd: Key Financials
Figure 32 F. Hoffmann-La Roche Ltd: Segmental Revenue
Figure 33 F. Hoffmann-La Roche Ltd: Geographical Revenue
Figure 34 Abbott: Key Financials
Figure 35 Abbott: Segmental Revenue
Figure 36 Abbott: Geographical Revenue
Figure 37 Danaher: Key Financials
Figure 38 Danaher: Segmental Revenue
Figure 39 Danaher: Geographical Revenue